Pharmacological treatment of adult ADHD in Europe

@article{Retz2011PharmacologicalTO,
  title={Pharmacological treatment of adult ADHD in Europe},
  author={W. Retz and P. Retz-Junginger and J. Thome and M. Roesler},
  journal={The World Journal of Biological Psychiatry},
  year={2011},
  volume={12},
  pages={89 - 94}
}
  • W. Retz, P. Retz-Junginger, +1 author M. Roesler
  • Published 2011
  • Medicine
  • The World Journal of Biological Psychiatry
  • Abstract Objectives: It is now widely accepted that ADHD is a frequent chronic condition with a lifelong perspective. Adult ADHD is a reliable and valid diagnosis. The disorder and the co-morbid conditions can place a severe burden on the patients, their families and their partners, requiring adequate treatment. Methods: A systematic literature search was conducted to review the available pharmacological treatment options for adults with ADHD in European countries. Results: Supported by meta… CONTINUE READING

    Topics from this paper.

    A conceptual designer-led New Product Development process model for Chinese SMEs
    2

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 72 REFERENCES
    Roles of serine protease inhibitor Kazal type 1 (SPINK1) in pancreatic diseases.
    37
    Pressure-independent baroreflex resetting produced by chronic infusion of angiotensin II in rabbits.
    61
    New insights into fragile X syndrome: from molecules to neurobehaviors.
    194
    Antioxidant activities of flavidin in different in vitro model systems.
    204